113 related articles for article (PubMed ID: 23958683)
1. Modulation of antitumour immune responses by intratumoural Stat1 expression.
Messina NL; Banks KM; Vidacs E; Martin BP; Long F; Christiansen AJ; Smyth MJ; Clarke CJ; Johnstone RW
Immunol Cell Biol; 2013 Oct; 91(9):556-67. PubMed ID: 23958683
[TBL] [Abstract][Full Text] [Related]
2. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY; Smyth MJ; Godfrey DI
J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
[TBL] [Abstract][Full Text] [Related]
3. STAT1 signaling shields T cells from NK cell-mediated cytotoxicity.
Kang YH; Biswas A; Field M; Snapper SB
Nat Commun; 2019 Feb; 10(1):912. PubMed ID: 30796216
[TBL] [Abstract][Full Text] [Related]
4. STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity.
Meissl K; Simonović N; Amenitsch L; Witalisz-Siepracka A; Klein K; Lassnig C; Puga A; Vogl C; Poelzl A; Bosmann M; Dohnal A; Sexl V; Müller M; Strobl B
Front Immunol; 2020; 11():2189. PubMed ID: 33042133
[TBL] [Abstract][Full Text] [Related]
5. A Human STAT1 Gain-of-Function Mutation Impairs CD8
Qian W; Miner CA; Ingle H; Platt DJ; Baldridge MT; Miner JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315996
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
[TBL] [Abstract][Full Text] [Related]
7. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
8. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
Kabingu E; Vaughan L; Owczarczak B; Ramsey KD; Gollnick SO
Br J Cancer; 2007 Jun; 96(12):1839-48. PubMed ID: 17505510
[TBL] [Abstract][Full Text] [Related]
10. The control of CD8+ T cell responses is preserved in perforin-deficient mice and released by depletion of CD4+CD25+ regulatory T cells.
Ataera H; Simkins HM; Hyde E; Yang J; Hermans IF; Petersen TR; Ronchese F
J Leukoc Biol; 2013 Oct; 94(4):825-33. PubMed ID: 23883515
[TBL] [Abstract][Full Text] [Related]
11. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
12. The susceptibility to cytotoxic T lymphocyte mediated lysis of chemically induced sarcomas from immunodeficient and normal mice.
Svane IM; Engel AM; Thomsen AR; Werdelin O
Scand J Immunol; 1997 Jan; 45(1):28-35. PubMed ID: 9010497
[TBL] [Abstract][Full Text] [Related]
13. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
14. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.
Combe CL; Curiel TJ; Moretto MM; Khan IA
Infect Immun; 2005 Aug; 73(8):4913-21. PubMed ID: 16041005
[TBL] [Abstract][Full Text] [Related]
15. NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours.
Indrová M; Símová J; Bieblová J; Bubeník J; Reinis M
Oncol Rep; 2011 Jan; 25(1):281-8. PubMed ID: 21109988
[TBL] [Abstract][Full Text] [Related]
16. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells.
Terao H; Harada M; Kurosawa S; Shinomiya Y; Ito O; Tamada K; Takenoyama M; Nomoto K
Immunobiology; 1996 Jul; 195(2):172-86. PubMed ID: 8877394
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.
Hannesdóttir L; Tymoszuk P; Parajuli N; Wasmer MH; Philipp S; Daschil N; Datta S; Koller JB; Tripp CH; Stoitzner P; Müller-Holzner E; Wiegers GJ; Sexl V; Villunger A; Doppler W
Eur J Immunol; 2013 Oct; 43(10):2718-29. PubMed ID: 23843024
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
19. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
Buhtoiarov IN; Sondel PM; Eickhoff JC; Rakhmilevich AL
Immunology; 2007 Mar; 120(3):412-23. PubMed ID: 17163960
[TBL] [Abstract][Full Text] [Related]
20. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo.
Gil MP; Salomon R; Louten J; Biron CA
Blood; 2006 Feb; 107(3):987-93. PubMed ID: 16210337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
